search
Back to results

Efficacy of ISST in Schizophrenia

Primary Purpose

Schizophrenia

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Integrated Social Cognitive and Behavioral Skills Therapy
Neurocognitive Remediation Therapy
Sponsored by
Heinrich-Heine University, Duesseldorf
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Schizophrenia focused on measuring social cognition, social skills, cognitive remediation, functional outcome, treatment adherence

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Written informed consent
  • DSM-IV-TR diagnosis of schizophrenia (295.10-30, 295.90)
  • PANSS at baseline: total score ≤ 75
  • Proficiency in German language.

Exclusion Criteria:

  • Lack of accountability
  • Positive urine drug-screening for illicit drugs at screening (except cannabinoids and benzodiazepines)
  • Serious suicidal risk at screening visit
  • Other relevant axis 1-diagnoses according to diagnostic interview (MINI);
  • Other relevant neurological or somatic disorders
  • Verbal IQ<80 (MWT-B)

Sites / Locations

  • Rheinhessen-Fachklinik Alzey
  • Vivantes Klinikum Am Urban
  • Dept. of Psychiatry and Psychotherapy, University of Bonn
  • Dept. of Psychiatry and Psychotherapy, University of Cologne
  • Dept. of Psychiatry and Psychotherapy, University of Düsseldorf
  • Dept. of Psychiatry and Psychotherapy, University of Tübingen

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Integrated Social Cognitive and Behavioral Skills Therapy

Neurocognitive Remediation Therapy

Arm Description

The Integrated Social Cognitive and Behavioral Skills Therapy (ISST) shall target expressive and interactional behavior skills together with those social cognitive domains (facial and prosodic affect recognition, social perception, theory-of-mind) known to be most impaired (Savla, 2012) and most closely associated with functional outcome (Fett, 2012) in schizophrenia.

The Neurocognitive Remediation Therapy (NCRT) shall target impairments in attention, memory, and executive functions as an active comparator to the ISST.

Outcomes

Primary Outcome Measures

All Cause Discontinuation
All Cause Discontinuation is defined as 1) not keeping appointments to treatment or diagnostic sessions as scheduled for more than 6 weeks and/or (2) not being traceable despite extensive efforts by the intervention team to reengage the patient throughout the entire intended treatment period and/or (3) withdrawal of consent by the patient (4) rater induced discontinuation of the study treatment (eg. for safety criteria) (5) not taking psychotropic drugs as prescribed for more than 14 consecutive days and/or (6) relevant worsening of symptoms.

Secondary Outcome Measures

Treatment Adherence 1
SES (Service Engagement Scale, Tait, Birchwood & Trower 2002)
Treatment Adherence 2
DAI-10 (Drug Attitude Scale, Goodstadt et al. 1978)
Treatment Adherence 3
PATHEV (Psychotherapy Attitude Scale, Schulte 2005)
Psychosocial Functioning 1
FROGS (Functional Remission of General Schizophrenia, Lorca et al. 2009)
Psychosocial Functioning 2
UPSA-Brief (University of California Performance Based Skills Assessment, Mausbach et al. 2007)
WHOQUOL-Bref (Quality of Life)
WHOQUOL-BREF (World Health Organization Quality of Life, WHO 1996)
Neurocognitive Performance (verbal memory)
VLMT (verbal learning and memory test, Helmstaedter, Lendt & Lux 2001
Neurocognitive Performance (working memory)
DSF, DSB (digit sequencing forward/backward, Wechsler 1981)
Neurocognitive Performance (processing speed 1)
DSST (digit symbol substitution test, Wechsler 1981)
Neurocognitive Performance (processing speed 2)
TMT-A, -B (Trail-Making-Test, Reitan 1956)
Socialcognitive Performance (affect recognition)
PFA (Picture of Facial Affect Test, Ekman & Friesen 1976)
Socialcognitive Performance (theory of mind)
MASC (Movie for the Assessment of Social Cognition, Dziobek et al. 2006)
Psychopathology/Symptoms 1
PANSS (Positive and Negative Syndrome Scale, Kay, Fiszbein & Opler 1987)
Psychopathology/Symptoms 2
CDSS (Calgary Depression Rating Scale for Schizophrenia, Addington, Addington & Maticka-Tyndale 1993)
Psychopathology/Symptoms 3
BSI (Brief Symptom Inventory, Derogatis & Melisaratos 1983)
Suicidality
Incidence of suicide/suicide attempt or severe suicidal crisis (CDSS Item 8 ≥ 2)
Severe symptom worsening
CGI (Clinical Global Impression Scale Item 2 ≥ 6)

Full Information

First Posted
February 3, 2016
Last Updated
August 2, 2022
Sponsor
Heinrich-Heine University, Duesseldorf
Collaborators
University Hospital, Bonn, University Hospital of Cologne, University Hospital Tuebingen, Zentralinstitut für Seelische Gesundheit Mannheim, University of Cologne, Rheinhessen-Fachklinik Alzey, Vivantes Klinikum am Urban
search

1. Study Identification

Unique Protocol Identification Number
NCT02678858
Brief Title
Efficacy of ISST in Schizophrenia
Official Title
Efficacy of "Integrated Social Cognitive and Behavioral Skills Therapy" (ISST) in Improving Functional Outcome in Schizophrenia
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
March 2016 (undefined)
Primary Completion Date
February 2021 (Actual)
Study Completion Date
March 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Heinrich-Heine University, Duesseldorf
Collaborators
University Hospital, Bonn, University Hospital of Cologne, University Hospital Tuebingen, Zentralinstitut für Seelische Gesundheit Mannheim, University of Cologne, Rheinhessen-Fachklinik Alzey, Vivantes Klinikum am Urban

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The ISST study investigates whether integrated social cognitive remediation and social behavioral skills therapy is more efficacious in improving functional outcome and treatment adherence than an active control treatment comprising drill-and-practice oriented neurocognitive remediation.
Detailed Description
Deficits in social functioning are a defining, very burdening feature of schizophrenia precluding patients from participating in a satisfying life. Traditional drug and psychosocial therapy and available specific treatment strategies that directly target single key determinants of functional outcome like neurocognition, social cognition, and social behavioral skills have produced only moderate effects leaving an urgent need for further optimization. The present trial aims to more efficaciously improve functional outcome by integrating social behavioral and social cognitive treatment strategies. Six months of "Integrated Social Cognitive and Behavioral Skills Therapy (ISST)" will be compared with "Neurocognitive Remediation Therapy (NCRT)" as active control condition in a randomized multicenter clinical trial using a two group pre-post design with 2x90 patients in the remitted early phase of schizophrenia. Beyond "all-cause-discontinuation" as common primary outcome of all clinical trials of the ESPRIT-consortium, measures of functional outcome and subjective quality of life, patient experience as well as neurocognitive, social-cognitive and social behavioral measures will be assessed at baseline (V0), after completion of treatment (V6), and after 6 months follow-up (V12). ISST is expected to reduce the one-year discontinuation rate by 20% compared with NCRT, and to be superior in functional outcome measures by an effect size of at least d=0.42.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia
Keywords
social cognition, social skills, cognitive remediation, functional outcome, treatment adherence

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
177 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Integrated Social Cognitive and Behavioral Skills Therapy
Arm Type
Experimental
Arm Description
The Integrated Social Cognitive and Behavioral Skills Therapy (ISST) shall target expressive and interactional behavior skills together with those social cognitive domains (facial and prosodic affect recognition, social perception, theory-of-mind) known to be most impaired (Savla, 2012) and most closely associated with functional outcome (Fett, 2012) in schizophrenia.
Arm Title
Neurocognitive Remediation Therapy
Arm Type
Active Comparator
Arm Description
The Neurocognitive Remediation Therapy (NCRT) shall target impairments in attention, memory, and executive functions as an active comparator to the ISST.
Intervention Type
Behavioral
Intervention Name(s)
Integrated Social Cognitive and Behavioral Skills Therapy
Other Intervention Name(s)
ISST
Intervention Description
The Integrated Social Cognitive and Behavioral Skills Therapy (ISST) is a newly developed treatment program. It is based on the Training of Affect Recognition (Wölwer et al. 2005) and common social skills trainings, which are combined in an integrated rather than a sequenced manner. ISST uses both repeated practice and strategy-based training, and consists of 12 individual sessions, 5 group sessions and 1 individual final session over a period of 6 months.
Intervention Type
Behavioral
Intervention Name(s)
Neurocognitive Remediation Therapy
Other Intervention Name(s)
NCRT
Intervention Description
The Neurocognitive Remediation Program (NCRT) is based on a neurocognitive training already used as active control condition in our earlier studies (Wölwer et al. 2005, Klingberg et al. 2011). The present version of NCRT is matched in dose, mode and scheme of application to the ISST, but differs from the ISST regarding targeted cognitive domains and preferred training strategy (predominantly drill and practice based). The NCRT provides the same amount of group interaction and companionship as well as the same amount of guided community activity as in the ISST, but is structured in such a way that interactional behavior is secondary (e.g. by competition-like tasks rather than cooperative tasks). Thus therapeutic attention and commitment are held constant across study conditions.
Primary Outcome Measure Information:
Title
All Cause Discontinuation
Description
All Cause Discontinuation is defined as 1) not keeping appointments to treatment or diagnostic sessions as scheduled for more than 6 weeks and/or (2) not being traceable despite extensive efforts by the intervention team to reengage the patient throughout the entire intended treatment period and/or (3) withdrawal of consent by the patient (4) rater induced discontinuation of the study treatment (eg. for safety criteria) (5) not taking psychotropic drugs as prescribed for more than 14 consecutive days and/or (6) relevant worsening of symptoms.
Time Frame
6 months, 12 months
Secondary Outcome Measure Information:
Title
Treatment Adherence 1
Description
SES (Service Engagement Scale, Tait, Birchwood & Trower 2002)
Time Frame
6 months, 12 months
Title
Treatment Adherence 2
Description
DAI-10 (Drug Attitude Scale, Goodstadt et al. 1978)
Time Frame
6 months, 12 months
Title
Treatment Adherence 3
Description
PATHEV (Psychotherapy Attitude Scale, Schulte 2005)
Time Frame
6 months, 12 months
Title
Psychosocial Functioning 1
Description
FROGS (Functional Remission of General Schizophrenia, Lorca et al. 2009)
Time Frame
6 months, 12 months
Title
Psychosocial Functioning 2
Description
UPSA-Brief (University of California Performance Based Skills Assessment, Mausbach et al. 2007)
Time Frame
6 months, 12 months
Title
WHOQUOL-Bref (Quality of Life)
Description
WHOQUOL-BREF (World Health Organization Quality of Life, WHO 1996)
Time Frame
6 months, 12 months
Title
Neurocognitive Performance (verbal memory)
Description
VLMT (verbal learning and memory test, Helmstaedter, Lendt & Lux 2001
Time Frame
6 months, 12 months
Title
Neurocognitive Performance (working memory)
Description
DSF, DSB (digit sequencing forward/backward, Wechsler 1981)
Time Frame
6 months, 12 months
Title
Neurocognitive Performance (processing speed 1)
Description
DSST (digit symbol substitution test, Wechsler 1981)
Time Frame
6 months, 12 months
Title
Neurocognitive Performance (processing speed 2)
Description
TMT-A, -B (Trail-Making-Test, Reitan 1956)
Time Frame
6 months, 12 months
Title
Socialcognitive Performance (affect recognition)
Description
PFA (Picture of Facial Affect Test, Ekman & Friesen 1976)
Time Frame
6 months, 12 months
Title
Socialcognitive Performance (theory of mind)
Description
MASC (Movie for the Assessment of Social Cognition, Dziobek et al. 2006)
Time Frame
6 months, 12 months
Title
Psychopathology/Symptoms 1
Description
PANSS (Positive and Negative Syndrome Scale, Kay, Fiszbein & Opler 1987)
Time Frame
6 months, 12 months
Title
Psychopathology/Symptoms 2
Description
CDSS (Calgary Depression Rating Scale for Schizophrenia, Addington, Addington & Maticka-Tyndale 1993)
Time Frame
6 months, 12 months
Title
Psychopathology/Symptoms 3
Description
BSI (Brief Symptom Inventory, Derogatis & Melisaratos 1983)
Time Frame
6 months, 12 months
Title
Suicidality
Description
Incidence of suicide/suicide attempt or severe suicidal crisis (CDSS Item 8 ≥ 2)
Time Frame
Assessed every 4-6 weeks from date of randomization until 1 year or until discontinuation (whatever came first)
Title
Severe symptom worsening
Description
CGI (Clinical Global Impression Scale Item 2 ≥ 6)
Time Frame
Assessed every 4-6 weeks from date of randomization until 1 year or until discontinuation (whatever came first)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Written informed consent DSM-IV-TR diagnosis of schizophrenia (295.10-30, 295.90) PANSS at baseline: total score ≤ 75 Proficiency in German language. Exclusion Criteria: Lack of accountability Positive urine drug-screening for illicit drugs at screening (except cannabinoids and benzodiazepines) Serious suicidal risk at screening visit Other relevant axis 1-diagnoses according to diagnostic interview (MINI); Other relevant neurological or somatic disorders Verbal IQ<80 (MWT-B)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wolfgang Wölwer, Prof. Dr.
Organizational Affiliation
Dept. of Psychiatry and Psychotherapy, University of Düsseldorf
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rheinhessen-Fachklinik Alzey
City
Alzey
Country
Germany
Facility Name
Vivantes Klinikum Am Urban
City
Berlin
Country
Germany
Facility Name
Dept. of Psychiatry and Psychotherapy, University of Bonn
City
Bonn
Country
Germany
Facility Name
Dept. of Psychiatry and Psychotherapy, University of Cologne
City
Cologne
Country
Germany
Facility Name
Dept. of Psychiatry and Psychotherapy, University of Düsseldorf
City
Duesseldorf
Country
Germany
Facility Name
Dept. of Psychiatry and Psychotherapy, University of Tübingen
City
Tübingen
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data shall be shared within the German research network ESPRIT (Enhancing Schizophrenia Prevention and Recovery through Innovative Treatments) as well as with other German research networks funded by the BMBF (call "Psychische Erkrankungen").
Citations:
PubMed Identifier
35800017
Citation
Wolwer W, Frommann N, Lowe A, Kamp D, Weide K, Bechdolf A, Brockhaus-Dumke A, Hurlemann R, Muthesius A, Klingberg S, Hellmich M, Schmied S, Meyer-Lindenberg A; ISST study group. Efficacy of Integrated Social Cognitive Remediation vs. Neurocognitive Remediation in Improving Functional Outcome in Schizophrenia: Concept and Design of a Multicenter, Single-Blind RCT (The ISST Study). Front Psychiatry. 2022 Jun 21;13:909370. doi: 10.3389/fpsyt.2022.909370. eCollection 2022.
Results Reference
derived

Learn more about this trial

Efficacy of ISST in Schizophrenia

We'll reach out to this number within 24 hrs